MCMirela Tinucci Costa

Mirela Tinucci Costa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mirela Tinucci Costa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Successive thromboembolism in splenic and portal veins of a dog with chronic kidney disease and pancreatitis – case report

    by Júlia Banhareli Tasso, Isabela Luiza Augusto, Marcus Vinícius Silveira, Mirela Tinucci Costa, Paola Castro Moraes, Rosemeri de Oliveira Vasconcelos, Andrigo Barboza de Nardi

    Thrombus refers to macrovascular sparing, which interrupts partially or completely blood flow. Its formation involves Virchow's triad, characterized by three main predisposing factors: endothelial injury, vascular stasis and hypercoagulability. The case reported was a canine, with a history of three thrombotic formations at different times of life, one in the splenic vein, undergoing splenectomy, and the other two in the right branch of the portal vein, undergoing surgical excision. The patient was under treatment with antithrombotic therapy, but with no response. Due to an uncompensated chronic kidney disease, the animal died a few weeks after the last procedure, with a cause of death of cardiogenic shock. It is mainly suspected that acute chronic kidney disease is the main cause of thrombosis, associated with chronic pancreatitis that re-aggravated in the first postoperative. However, the formation of thromboembolism is multifactorial, and its development and occurrence is still not fully elucidated. Thus, more studies and tests are needed, such as thromboelastometry.

  • Open Access

    RESISTÊNCIA BACTERIANA NA MEDICINA VETERINÁRIA E SUA RELAÇÃO COM A SAÚDE PÚBLICA

    by Gabriela Ramos Marques, Annelise Carla Camplesi, Mirela Tinucci Costa

    Na medicina veterinária, antibióticos são amplamente utilizados tanto em animais de companhia, quanto em animais de produção, no tratamento terapêutico, metafilático ou profilático de infecções bacterianas e foi utilizado como promotores de crescimento no passado. O uso desses antimicrobianos de forma rotineira e irracional tem causado seleção de bactérias multirresistentes, reduzindo o número de antimicrobianos eficazes. Além disso, o frequente contato entre animais e seres humanos, aumenta o risco de infecções e de transmissão cruzada de dessas bactérias. O presente trabalho tem como objetivo abordar o tema sobre resistência bacteriana na medicina veterinária e sua relação com a saúde pública.